## Clinical Scenario: Hepatic Echinococcosis This patient has **symptomatic hepatic cystic echinococcosis** (hydatid disease) caused by *Echinococcus granulosus*. The presence of daughter cysts on imaging is pathognomonic for this infection. The shepherd's occupational exposure (contact with infected dogs) and endemic geography (Himalayas) are typical risk factors. ## Management Algorithm for Hepatic Echinococcosis ```mermaid flowchart TD A[Hepatic echinococcosis diagnosed]:::outcome --> B{Cyst characteristics?}:::decision B -->|Small, inactive| C[Observation with serial imaging]:::action B -->|Large, symptomatic, uncomplicated| D{Suitable for PAIR?}:::decision D -->|Yes| E[PAIR + albendazole]:::action D -->|No| F[Surgical excision]:::action B -->|Complicated/ruptured| G[Surgical intervention]:::action E --> H[Monitor response at 3-6 months]:::action F --> I[Pericystectomy or partial cystectomy]:::action ``` ## Why PAIR Is the Best Choice Here **Key Point:** **PAIR** (Percutaneous Aspiration, Injection, Re-aspiration) is now the **first-line percutaneous intervention** for uncomplicated hepatic echinococcosis, especially for cysts 5–15 cm in diameter with daughter cysts. **High-Yield:** PAIR advantages: - Minimally invasive; lower morbidity than open surgery - Can be performed under ultrasound or CT guidance - Sclerosant (hypertonic saline, ethanol, or albendazole) kills protoscolices - Requires **concurrent albendazole** (10–15 mg/kg/day for ≥4 weeks before and after) - Success rate: 80–90% for uncomplicated cysts - Suitable for this patient: large, symptomatic, with daughter cysts, no pulmonary involvement ## Cyst Classification (WHO-IWGE) | Type | Imaging | Viability | Management | |------|---------|-----------|-------------| | **CL** | Cystic lesion (no daughter cysts) | Inactive | Observation | | **CE1** | Unilocular, anechoic | Active | PAIR or surgery | | **CE2** | Multilocular, daughter cysts | Active | **PAIR or surgery** | | **CE3** | Daughter cysts + degenerating wall | Transitional | PAIR or surgery | | **CE4** | Heterogeneous, no daughter cysts | Inactive | Observation | | **CE5** | Calcified rim | Dead | Observation | This patient has **CE2** (daughter cysts visible)—ideal for PAIR. ## Why Not the Other Options? **Immediate Surgery:** While surgical excision (pericystectomy) is effective, it carries higher morbidity (bile leak, infection, anaphylaxis if cyst ruptures) and longer hospital stay. PAIR is preferred as first-line for uncomplicated cysts suitable for percutaneous access. **Albendazole Monotherapy:** Chemotherapy alone is **not curative** for large cysts. It may prevent growth or cause partial involution but cannot reliably eliminate established cysts. It is used as **adjunctive therapy** (before/after PAIR or surgery) or for inoperable/disseminated disease. **Observation Alone:** The cyst is **symptomatic** (RUQ pain, palpable mass) and **large** (daughter cysts visible). Observation is reserved for small, incidental, inactive cysts (CE4, CE5). Active symptomatic cysts require intervention. **Clinical Pearl:** The presence of daughter cysts indicates an **active, proliferating cyst**. These require intervention; observation risks cyst growth, rupture, and anaphylactic shock. **Mnemonic: PAIR PROTOCOL** - **P**ercutaneous access under imaging - **A**spiration of cyst fluid (diagnostic + therapeutic) - **I**njection of sclerosant (kills protoscolices) - **R**e-aspiration to remove dead material - **Plus albendazole cover** (4 weeks before, 4 weeks after)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.